AIM: To investigate the relationship of urokinase type plasminogen activator receptor (uPAR) and vascular endothelial growth factor (VEGF) expression with clinical and pathological characteristics of human gallbladder cancer. METHODS: uPAR and VEGF expressions in 68 gallbladder cancer tissues were detected with anti-receptor immunohistochemical stain. RESULTS: Expression rate of uPAR was 57.4% (39/68), and VEGF 51.5% (35/68) in gallbladder cancer tissues. Expression of both uPAR and VEGF was significantly related to metastasis, but not significantly correlated with differentiation stage and size of gallbladder cancer. CONCLUSION: Expression of uPAR and VEGF may be an invasive phenotype of gallbladder cancer and indicator for predicting prognoses, and uPAR expression is significantly correlated with the expression of VEGF.
AIM: To investigate the relationship of urokinase type plasminogen activator receptor (uPAR) and vascular endothelial growth factor (VEGF) expression with clinical and pathological characteristics of humangallbladder cancer. METHODS:uPAR and VEGF expressions in 68 gallbladder cancer tissues were detected with anti-receptor immunohistochemical stain. RESULTS: Expression rate of uPAR was 57.4% (39/68), and VEGF 51.5% (35/68) in gallbladder cancer tissues. Expression of both uPAR and VEGF was significantly related to metastasis, but not significantly correlated with differentiation stage and size of gallbladder cancer. CONCLUSION: Expression of uPAR and VEGF may be an invasive phenotype of gallbladder cancer and indicator for predicting prognoses, and uPAR expression is significantly correlated with the expression of VEGF.
Authors: Alice Hemsen; Lutz Riethdorf; Nils Brünner; Jürgen Berger; Sebastian Ebel; Christoph Thomssen; Fritz Jänicke; Klaus Pantel Journal: Int J Cancer Date: 2003-12-20 Impact factor: 7.396
Authors: Shashi R Harvey; Thelma C Hurd; Gabor Markus; Maisie I Martinick; Remedios M Penetrante; Dongfeng Tan; Preeti Venkataraman; Nisha DeSouza; Sheila N J Sait; Deborah L Driscoll; John F Gibbs Journal: Clin Cancer Res Date: 2003-10-15 Impact factor: 12.531
Authors: Andreas Machner; Anja Baier; Aline Wille; Susanne Drynda; Géza Pap; Andreas Drynda; Christian Mawrin; Frank Bühling; Steffen Gay; Wolfram Neumann; Thomas Pap Journal: Arthritis Res Ther Date: 2003-06-30 Impact factor: 5.156
Authors: Sven H Loosen; Annemarie Breuer; Frank Tacke; Jakob N Kather; Joao Gorgulho; Patrick H Alizai; Jan Bednarsch; Anjali A Roeth; Georg Lurje; Sophia M Schmitz; Jonathan F Brozat; Pia Paffenholz; Mihael Vucur; Thomas Ritz; Alexander Koch; Christian Trautwein; Tom F Ulmer; Christoph Roderburg; Thomas Longerich; Ulf P Neumann; Tom Luedde Journal: JHEP Rep Date: 2020-01-31